Stockreport

Eliem Therapeutics Reports Second Quarter Financial Results

Eliem Therapeutics, Inc  (ELYM) 
PDF Eliem completed the acquisition of Tenet Medicines and concurrent $120 million private placement Eliem to host an Investor Day later in the year to provide an overview [Read more]